Rocket Pharmaceuticals (RCKT) is rated Hold as its $3.20 share price slightly exceeds the $3.08 risk-adjusted fair value.

Gravity from Entropy theory offers a new resolution to one of physics' oldest paradoxes: how the universe builds galaxies and ...

Hybrid hash function post-quantum cryptography research: a new paper on IACR ePrint formalizes a construction whose collision ...

Good day, and thank you for standing by. Welcome to the Baldwin Group Second Quarter 2026 Earnings Call. [Operator Instructions] Please be advised that today's conference is being recorded. I would ...

LymeAlert will hit the market in August. The latest tool against the tick-borne illness could become a medicine cabinet ...

The Arctic is no longer just a frozen frontier — it’s a battleground for the next generation of great-power competition. As ...

Apple's iOS 26.6 update fixes nearly 90 security flaws, including major WebKit and Kernel bugs, giving iPhone users strong reasons to update now.

From basic biology in nematodes to FDA-approved medicines, explore how RNA interference transformed gene silencing and modern ...

Tech executives across the world are warning that the biggest change to their job from AI is the speed at which they need to ...

Spread the love“`html When you’re diving into the world of vector graphics, whether for professional design, personal ...

Spread the loveIf you’ve ever spent hours meticulously crafting a vector graphic, you know the feeling: your hand aches, your ...